Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05376787 · ClinicalTrials.gov registry record
Verify the Performance of the Neutral Electrode (NE) Adhesives
A clinical trial, sponsored by Medline Industries.
- Completed
- Registry status
- 20
- Enrollment target
NCT05376787: Completed study, sponsored by Medline Industries.
NCT05376787 is a clinical trial that has completed, run by Medline Industries. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05376787 has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the neutral electrode 21pad adhesion to the skin in accordance with international standard IEC 60601-2-2 section 201.15.101.7. A neutral electrode is placed on the body of patients undergoing surgery that involves the use of electric current, to protect them from the harmful effects of the electricity.
Primary Outcome
To determine the percentage of adhesion separation by only measuring test results that had no more than 5% of the NE adhesive area separated. At Point A where the NE connects to the pad, connect a cord to pull on the cable. Pull for 10 to 10.25 minutes, in a plane parallel to the NE pad and in a direction away from the center of the pad, with 10 to 11N (1.02 to 1.12kg) of force in the direction along the minor dimension of the pad. Set the height of the pulley so that the direction of pull shal
Interventions
- DEVICE Medline NE Grounding Pad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-05-30 |
| Est. Completion | 2022-06-10 |
What the finished NCT05376787 record still lists
NCT05376787 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Medline NE Grounding Pad is the first listed.
NCT05376787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05376787 about?
NCT05376787 is a clinical study titled "Verify the Performance of the Neutral Electrode (NE) Adhesives". The purpose of this research study is to determine the neutral electrode 21pad adhesion to the skin in accordance with international standard IEC 60601-2-2 section 201.15.101.7. A neutral electrode is placed on the body of patients undergoing surgery that involves the use of electric current, to pro...
What is the current status of trial NCT05376787?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-05-30. Estimated completion is 2022-06-10.
What interventions are being tested in trial NCT05376787?
The interventions under investigation include: Medline NE Grounding Pad (DEVICE).
Who is sponsoring clinical trial NCT05376787?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI